Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

British Journal of Psychiatry

Volumn 191, Issue OCT., 2007, Pages 325-334

  Théberge, Jean ^a,d   Williamson, Kate E ^a   Aoyama, Naoko ^a   Drost, Dick J ^a   Manchanda, Rahul ^a   Malla, Ashok K ^b   Northcott, Sandra ^a   Menon, Ravi S ^c   Neufeld, Richard W J ^a   Rajakumar, Nagalingam ^a   Pavlosky, William ^d   Densmore, Maria ^a   Schaefer, Betsy ^a   Williamson, Peter C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; CLOZAPINE; DIAZEPAM; FLUOXETINE; GLUTAMINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROATE SEMISODIUM; VENLAFAXINE; ZIPRASIDONE; ZOPICLONE;

ADULT; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; PARIETAL LOBE; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS;

ADULT; CASE-CONTROL STUDIES; FEMALE; FUNCTIONAL LATERALITY; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SCHIZOPHRENIA; THALAMUS; TIME FACTORS;

EID: 35048894824     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.106.033670     Document Type: Article

References (37)

1. Alexander, G. E., Crutcher, M. D. & DeLong, M. R. (1990) Basal ganglia-thalamocortical circuits: parallel Substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Progress in Brain Research, 85, 119-146.
2. Andreasen, N. C. (1983a) Scale for the Assessment of Negative Symptoms (SANS). University of Iowa.
3. Andreasen, N. C. (1983b) Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa.
4. Ashburner, J. & Friston, K. J. (2000) Voxel-based morphometry - the methods. NeuroImage, 11, 805-821.
5. Ashburner, J. & Friston, K. J. (2001) Why voxel-based morphometry should be used. NeuroImage, 14, 1238-1243.
6. Bartha, R., Williamson, P. C., Drost, D. J., et al (1997) Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls using proton magnetic resonance spectroscopy. Archives of General Psychiatry, 54, 959-965.
7. Bartha, R., Drost, D. J. & Williamson, P. C. (1999) Factors affecting the quantification of short echo in-vivo IH MR spectra: prior knowledge, peak elimination, and filtering. NMR in Biomedicine, 12, 205-216.
8. Bartha, R., Drost, D. J., Menon, R. S., et al (2000a) Comparison of the quantification precision of human short echo time IH spectroscopy at 1.5 and 4.0 Tesla. Magnetic Resonance in Medicine, 44, 185-192.
9. Bartha, R., Drost, D. J., Menon, R. S., et al (2000b) Spectroscopic lineshape correction by QUECC: combined QUALITYdeconvolution and eddy current correction. Magnetic Resonance in Medicine, 44, 641-645.
10. Bezchlibnyk-Butler, K. Z. & Jeffries, J. J. (2002) Clinical Handbook of Psychotropic Drugs (12th edn). Hogrefe & Huber.
11. Box, G. E. P. (1953) Non-normality and tests on variance. Biometrika, 40, 318-335.
12. Box, G. E. P. (1954) Some theorems on quadratic forms applied in the study of analysis of variance in the one-way classification. Annals of Mathematical Statistics, 25, 290-302.
13. Bryden, P. (1977) Measuring handedness with questionnaires. Neuropsychologia, 15, 617-624.
14. First, M. B., Spitzer, R. L., Gibbon, M., et al (1997) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York State Psychiatric Institute, Biometrics Research.
15. Gogtay, N., Sporn, A., Clasen, L. S., et al (2004) Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Archives of General Psychiatry, 61, 17-22.
16. Hertz, L., Dringen, R., Schousboe, A., et al (1999) Astrocytes: glutamate producers for neurons. Journal of Neuroscience Research, 57, 417-428.
17. Honea R., Crow T. J., Passingham D., et al (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. American Journal of Psychiatry, 162, 2233-2245.
18. Hummel, T. J. & Sligo, J. (1971) An empirical comparison of univariate and multivariate analysis of variance procedures. Psychological Bulletin, 76, 49-57.
19. Jafari, M. R., Zhang, Y. & Yan, J. (2007) Multiparametric changes in the receptive field of cortical auditory neurons induced by thalamic activation in the mouse. Cerebral Cortex, 17, 71-80.
20. 31P-MRS chemical shift imaging study at 4 Tesla. British Journal of Psychiatry, 184, 409-415.
21. Milligan, G. W., Wong, D. S. & Thompson, P. A. (1987) Robustness properties of nonorthogonal analysis of variance. Psychological Bulletin, 101, 464-470.
22. O'Donnell, P. & Grace, A. A. (1998) Dysfunction in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophrenia Bulletin, 24, 267-283.
23. Olney, J. W. & Farber, N. B. (1995) Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry, 52, 998-1007.
24. Rowland, L. M., Bustillo, J. R., Mullins, P. G., et al (2005) Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. American Journal of Psychiatry, 162, 394-396.
25. Selemon, L. D. & Goldman-Rakic, P. S. (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry, 45, 17-25.
26. Shenton, M. E., Dickey, C. C., Frumin, M., et al (2001) A review of MRI findings in schizophrenia. Schizophrenia Research, 49, 1-52.
27. Steen, R. G., Hamer, R. M. & Lieberman, J. A. (2005) Measurements of brain metabolites by IH-MRS in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30, 1949-1962.
28. Steen, R. G., Mull, C., McClure, R., et al (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry, 188, 510-518.
29. Stevens, J. (1996) Applied Multivariate Statistics for the Social Sciences (3rd edn). Erlbaum.
30. Théberge, J., Bartha, R., Drost, D. J., et al (2002) Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry, 159, 1944-1946.
31. Théberge, J., Al-Semaan, Y., Williamson, P. C., et al (2003) Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. American Journal of Psychiatry, 160, 2231-2233.
32. Thompson, P. M., Vidal, C., Giedd, J. N., et al (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Science of the USA, 98, 11650-11655.
33. Tibbo, P., Hanstock, C., Valiakalayil, A., et al (2004) 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. American Journal of Psychiatry, 161, 1116-1118.
34. Weinberger, N. M. (1995) Dynamic regulation of receptive fields and maps in the adult sensory cortex. Annual Review of Neuroscience, 18, 129-158.
35. White, T., O'Leary, D., Magnotta, V., et al (2001) Anatomic and functional variability: the effects of filter size in group fMRI data analysis. NeuroImage, 13, 577-588.
36. Williamson, P. (2006) Mind, Brain, and Schizophrenia, pp. 110-112. Oxford University Press.
37. Woods, S. W. (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667.